{"organizations": [], "uuid": "475e0a55e631b42804e1a1c8cac1d15c20d2e9cd", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-capricor-announces-initiation-of-h/brief-capricor-announces-initiation-of-hope-2-clinical-trial-of-cap-1002-for-duchenne-muscular-dystrophy-idUSASC09Y6B", "country": "US", "domain_rank": 408, "title": "BRIEF-Capricor Announces Initiation Of Hope-2 Clinical Trial Of Cap-1002 For Duchenne Muscular Dystrophy", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-30T14:30:00.000+03:00", "replies_count": 0, "uuid": "475e0a55e631b42804e1a1c8cac1d15c20d2e9cd"}, "author": "", "url": "https://www.reuters.com/article/brief-capricor-announces-initiation-of-h/brief-capricor-announces-initiation-of-hope-2-clinical-trial-of-cap-1002-for-duchenne-muscular-dystrophy-idUSASC09Y6B", "ord_in_thread": 0, "title": "BRIEF-Capricor Announces Initiation Of Hope-2 Clinical Trial Of Cap-1002 For Duchenne Muscular Dystrophy", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "nical trial of cap-1002 for duchenne muscular dystrophy reuters staff", "sentiment": "none"}, {"name": "capricor therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 31 AM / Updated 27 minutes ago BRIEF-Capricor Announces Initiation Of Hope-2 Clinical Trial Of Cap-1002 For Duchenne Muscular Dystrophy Reuters Staff 1 Min Read\n Capricor Therapeutics Inc:\n* CAPRICOR ANNOUNCES INITIATION OF HOPE-2 CLINICAL TRIAL OF CAP-1002 FOR DUCHENNE MUSCULAR DYSTROPHY Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-30T14:30:00.000+03:00", "crawled": "2018-04-30T14:48:29.010+03:00", "highlightTitle": ""}